[go: up one dir, main page]

WO2009041700A1 - 医薬組成物 - Google Patents

医薬組成物 Download PDF

Info

Publication number
WO2009041700A1
WO2009041700A1 PCT/JP2008/067693 JP2008067693W WO2009041700A1 WO 2009041700 A1 WO2009041700 A1 WO 2009041700A1 JP 2008067693 W JP2008067693 W JP 2008067693W WO 2009041700 A1 WO2009041700 A1 WO 2009041700A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
stretch
pharmaceutical composition
composition
nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/067693
Other languages
English (en)
French (fr)
Inventor
Manabu Nozaki
Shigeki Sawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of WO2009041700A1 publication Critical patent/WO2009041700A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

【課題】化合物１による神経伸長阻害作用を抑制し得る組成物、ならびに神経細胞の伸長を顕著に促進することが可能な神経伸長を促進することが可能な組成物を提供することを主な目的とする。 【解決手段】化合物１と化合物２を含有することを特徴とする医薬組成物。化合物１の少なくとも１種と化合物２に加えて化合物３を含有することを特徴とする神経伸長促進用組成物。
PCT/JP2008/067693 2007-09-28 2008-09-29 医薬組成物 Ceased WO2009041700A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007256016A JP5376785B2 (ja) 2007-09-28 2007-09-28 医薬組成物
JP2007-256016 2007-09-28

Publications (1)

Publication Number Publication Date
WO2009041700A1 true WO2009041700A1 (ja) 2009-04-02

Family

ID=40511578

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/067693 Ceased WO2009041700A1 (ja) 2007-09-28 2008-09-29 医薬組成物

Country Status (2)

Country Link
JP (1) JP5376785B2 (ja)
WO (1) WO2009041700A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579584A (zh) * 2011-01-06 2012-07-18 赵能 一种疏通经络治理面瘫的保健丸

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5376786B2 (ja) * 2007-09-28 2013-12-25 小林製薬株式会社 神経細胞賦活組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001504104A (ja) * 1996-11-06 2001-03-27 ブリストル―マイヤーズ・スクイブ・カンパニー アルツハイマー病の治療法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3768800A (en) * 1999-03-26 2000-10-16 Emil H. Franssen Treatment of brain changes with myelin protective agents
JP5376786B2 (ja) * 2007-09-28 2013-12-25 小林製薬株式会社 神経細胞賦活組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001504104A (ja) * 1996-11-06 2001-03-27 ブリストル―マイヤーズ・スクイブ・カンパニー アルツハイマー病の治療法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SWEENEY, C.J. ET AL.: "Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer", CLIN CANCER RES, vol. 12, no. 2, 2006, pages 536 - 542 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579584A (zh) * 2011-01-06 2012-07-18 赵能 一种疏通经络治理面瘫的保健丸

Also Published As

Publication number Publication date
JP5376785B2 (ja) 2013-12-25
JP2009084207A (ja) 2009-04-23

Similar Documents

Publication Publication Date Title
WO2008106128A3 (en) CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
WO2008024497A3 (en) INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
WO2009075835A8 (en) CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
WO2010108074A3 (en) Inhibitors of pi3 kinase
TN2012000248A1 (en) Novel spiropiperidine compounds
WO2011014795A3 (en) Compounds and compositions as syk kinase inhibitors
MX2012004420A (es) Compuestos de espiropiperidino y uso farmaceutico de los mismos para tratar diabetes.
WO2010003133A3 (en) Cdk modulators
WO2008103470A3 (en) Oncogenic-ras-signal dependent lethal compounds
SG179034A1 (en) 2 -aminodihydro [1, 3] thiazines as bace 2 inhibitors for the treatment of diabetes
IL198979A (en) Enzyme inhibitors diacylglycerol o-acetyltransferase type 1
WO2011033265A8 (en) Pharmaceutical compounds
WO2008070268A3 (en) Pharmaceutical compositions
PH12013500879A1 (en) Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b] pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors
WO2009038412A3 (en) Beta-secretase inhibiting compounds
WO2011047055A3 (en) Novel mek inhibitors, useful in the treatment of diseases
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
MY165041A (en) Composition for improving brain function and method for improving brain function
WO2010123959A3 (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
WO2011088160A3 (en) Novel cyp17 inhibitors
WO2010062506A3 (en) Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
WO2009129208A3 (en) Compositions and methods of inducing endoplasmic reticulum stress reponse
WO2010072770A3 (en) Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
WO2009065090A3 (en) Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition
GEP20125570B (en) Use of indazolemethoxyalkanoic acid for reducing levels of triglycerides, cholesterol and glucose

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08834472

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08834472

Country of ref document: EP

Kind code of ref document: A1